Relentless Health Value is the podcast for business leaders working in payer/insurance carrier and provider organizations, as well as for pharmaceutical, medical device, patient advocacy, and other health care organizations. Health care–oriented venture capitalists (VCs) and digital health entrepreneurs also regularly engage with our show. Finally, we have a growing contingent of employer CFOs and benefits professionals who tune in.
The podcast mission is to help transform health care by fostering collaboration and breaking down silos. Our panel of expert guests connects you with other health care leaders trying to achieve the quadruple aim of improving population health and patient and provider experience, while managing costs effectively.
Relentless Health Value is one of the oldest and largest podcasts dedicated to health care industry decision makers trying to do the right thing.
EP306: A Deep Dive Into Amazon’s Pharmacy and the Amazon Pharmacy Model Some Employers Are Running With, With Ge Bai, PhD, CPA
In this health care podcast, I talk to Ge Bai about Amazon’s pharmacy business. Ge Bai, PhD, CPA, is an associate professor of accounting at Johns Hopkins Carey School of Business. She's also associate professor of health policy and management at Johns Hopkins Bloomberg School of Public Health. Ge trained as an accounting researcher originally looking into chargemasters for her dissertation. From there, she checked out health care pricing and contracting issues.
EP305: The 1% Most Expensive Claimants Racking Up Massive FFS Bills and Still Not Getting the Help They Need From Our Health Care System, With Darrell Moon, CEO of Orriant
My guest in this health care podcast is Darrell Moon, who is the CEO over at Orriant.
I was super intrigued by some of the work that Darrell and his team are doing regarding high-cost claimants. Year after year after year, these individuals—I call them hyper-users during this episode, but it’s possible I made that term up myself—these hyper-users were getting all kinds of expensive health care, while at the same time, they were not getting any better.
AEE12: Steve Blumberg and I Discuss the 2020 Humana Value-based Care Report
I wanted to get an expert’s take on this report and the reaction to the report and could think of no better person than Steve Blumberg, who has worked in value-based care delivery on the provider and on the payer side.
EP304: How a Provider Population Health Leader Who Went to Work for a Payer Thinks About Health Care Transformation, With Steve Blumberg, VP of Practice Transformation for GuideWell Health
I wanted to find out a bunch of things from Steve, but the main one is this: How do—if they, in fact, do—payviders improve care for patients? Or what does it take for an organizational structure to drive Triple Aim results?
Encore! EP216: How Medicare Part D Plans Became Addicted to Drug Rebates, With Chris Sloan From Avalere Health
Should rebates go away, it’s actually a big deal that fundamentally could upend the heretofore-not-transparent messy middle of drug pricing. I’ll let Chris Sloan, associate principal over at Avalere Health, explain. Spoiler alert: The impact of killing pharma rebates to plans and PBMs (pharmacy benefit managers)? Bottom line, everybody’s insurance premiums go up in the current model when rebates go away.
Encore! EP231: Pharmaceutical Contracting, PBMs, Pharmacies, Employers, and the Latest HHS Rebate Proposal, With AJ Loiacono, CEO of Capital Rx
The first time this HHS proposal was presented in 2019, I talked to AJ Loiacono, who’s the CEO over at Capital Rx. I was a little over-cocky relative to how well I understood the hidden machinations behind pharmacy Rxs being adjudicated, and AJ does an amazing job explaining it. This is incredibly relevant as we contemplate potentially who gets a piece of the action moving forward.